DEA Sued Over Delays To Open Records For Psychedelics And Cannabis

The Drug Enforcement Administration (DEA) has been sued over a failure to respond in due time to requests for psychedelics and cannabis records, reported Marijuana Moment.

This new suit centers on the DEA’s alleged “unlawful policy of delaying responses to Freedom of Information Act (FOIA) requests, specifically pertaining to psychedelics and marijuana documents that advocates say they’ve sought for legal and journalistic purposes."

DEA “flouts these principles of transparency and good government,” reads the lawsuit. Attorney General Merrick Garland issued a Justice Department FOIA guidance on policy, emphasizing that "agencies should be responsive to requests in an open and timely manner."

Among the sues, a Texas doctor cited in Texas federal district court the erroneous DEA’s interpretation of “right to try” laws as it concerns psilocybin. Attorneys Matt Zorn and Kathryn Tuckerboth worked on that case as well.

Plaintiffs have laid out the reasons why they are impacted by DEA’s refractoriness on FOIA requests, "the agency has adopted an unlawful policy and pattern or practice of designating requests as “complex,” regardless of the actual complexity of the documents sought," reads the lawsuit.

For its part, the DEA has said that the requests raise “unusual circumstances” that exempt them from the statutorily imposed timeline for responding. Also, the DEA defense says that "assigning the FOIA inquiries is “complex” because retrieving the documents in question might involve coordinating with outside offices."

“This policy and pattern or practice rest on a perversion of FOIA’s plain language,” stated the suit. “Plaintiffs are attorneys and their clients who have submitted FOIA requests to DEA only to have the agency unlawfully ignore the statute’s processing deadlines merely because the requested records were not present at DEA’s FOIA office.”

Now, the plaintiffs are asking the court to enjoin the Justice Department and DEA “from applying the unlawful policy and pattern or practice and directing defendants to take immediate corrective action to prevent future FOIA violations.”
Image by Benzinga

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisMarketsFOIAFreedom of Information ActU.S. Attorney General Merrick GarlandU.S. Drug Enforcement Administration
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...